Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA as the measure of average blood glucose levels for the 3 months preceding the HbA test date. The use of this measure highlights the long-establi...

Celý popis

Podrobná bibliografia

Vydané v:	The lancet. Diabetes & endocrinology Ročník 11; číslo 1; s. 42
Hlavní autori:	Battelino, Tadej, Alexander, Charles M, Amiel, Stephanie A, Arreaza-Rubin, Guillermo, Beck, Roy W, Bergenstal, Richard M, Buckingham, Bruce A, Carroll, James, Ceriello, Antonio, Chow, Elaine, Choudhary, Pratik, Close, Kelly, Danne, Thomas, Dutta, Sanjoy, Gabbay, Robert, Garg, Satish, Heverly, Julie, Hirsch, Irl B, Kader, Tina, Kenney, Julia, Kovatchev, Boris, Laffel, Lori, Maahs, David, Mathieu, Chantal, Mauricio, Dídac, Nimri, Revital, Nishimura, Rimei, Scharf, Mauro, Del Prato, Stefano, Renard, Eric, Rosenstock, Julio, Saboo, Banshi, Ueki, Kohjiro, Umpierrez, Guillermo E, Weinzimer, Stuart A, Phillip, Moshe
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.01.2023
Predmet:	Adolescent Blood Glucose - analysis Blood Glucose Self-Monitoring Child Clinical Trials as Topic Diabetes Mellitus, Type 1 - drug therapy Humans Hyperglycemia - therapy Hypoglycemia - prevention & control Prospective Studies
ISSN:	2213-8595, 2213-8595
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!